「fortherepublic of kiribati」の検索結果
135件：121～125件目を表示
-
学会发表 | 研究与开发 | 千寿制药株式会社
試験 堀 裕一、和田智之、尾松和則 See more 海外 ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response...
https://www.senju.co.jp/chinese/rd/society/ -
acturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibiti...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
Communications with Customers and Provision of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Cente...
https://www.senju.co.jp/english/about/csr01.html -
acturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibiti...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
6, 2026 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf